Title of article
Switching to exemestane after 2–3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen: Abstracted from: Coombes RC, Hall E, Gibso
Author/Authors
Davies، نويسنده , , Christina، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2004
Pages
6
From page
583
To page
588
Journal title
Cancer Treatment Reviews
Serial Year
2004
Journal title
Cancer Treatment Reviews
Record number
1834574
Link To Document